Request Deal Involvement

Wellington Management Company led a $116M Series V funding round in Entrada Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Real Chemistry

pr advisors

Real Chemistry

White & Case

legal advisors

White & Case

or

Principals

ENTRADA THERAPEUTICS INC

target

ENTRADA THERAPEUTICS INC

WELLINGTON MANAGEMENT

bidder

WELLINGTON MANAGEMENT

REDMILE GROUP

bidder

REDMILE GROUP

TCG CROSSOVER

bidder

TCG CROSSOVER

GREENSPRING ASSOCIATES INC

bidder

GREENSPRING ASSOCIATES INC

POINT72 VENTURES

bidder

POINT72 VENTURES

QATAR INVESTMENT AUTHORITY

bidder

QATAR INVESTMENT AUTHORITY

MOORE STRATEGIC VENTURES

bidder

MOORE STRATEGIC VENTURES

GOLDMAN SACHS INC

bidder

GOLDMAN SACHS INC

CUREDUCHENNE VENTURES

bidder

CUREDUCHENNE VENTURES

MPM CAPITAL

bidder

MPM CAPITAL

ROCHE VENTURE FUND

bidder

ROCHE VENTURE FUND

MRL VENTURES FUND

bidder

MRL VENTURES FUND

AGENT CAPITAL

bidder

AGENT CAPITAL

5AM VENTURES LLC

bidder

5AM VENTURES LLC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Wellington Management Company led a $116M Series V funding round in Entrada Therapeutics.